Systematic review / meta-analysis / 2020
Pomegranate supplementation lowered select inflammatory markers but not endothelial adhesion molecules in adults
A meta-analysis of 16 randomized controlled trials with 572 participants evaluated the effects of pomegranate supplementation compared to placebo. Pomegranate intake significantly lowered hs-CRP (WMD: -6.57 mg/L, 95% CI: -10.04 to -3.10), IL-6 (WMD: -1.68 pg/mL, 95% CI: -3.52 to 0.157), and TNF-alpha (WMD: -2.37 pg/mL, 95% CI: -3.67 to -1.07). However, no significant effects were observed for CRP, E-selectin, ICAM, VCAM, or MDA.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 572 participants across 16 randomized controlled trials
- What was measured
- Inflammatory and endothelial dysfunction biomarkers
THE PAPER
The effects of pomegranate supplementation on biomarkers of inflammation and endothelial dysfunction: A meta-analysis and systematic review.
Wang P, Zhang Q, Hou H, Liu Z, Wang L, Rasekhmagham R, Kord-Varkaneh H, Santos HO, Yao G. Complement Ther Med, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.